Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a research study of SP-102, an experimental medication designed to relieve pain in
patients with a specific type of leg pain. The mediation is given once by your healthcare
professional, with a possibility of a second injection as early as about 1 month after the
first treatment.
The purpose of the study is to measure how well a single injection of the experimental
medication, SP-102, relieves pain. The study will also investigate the side effects of
SP-102.
Phase:
Phase 3
Details
Lead Sponsor:
Scilex Pharmaceuticals, Inc.
Collaborators:
Semnur Pharmaceuticals, Inc. Worldwide Clinical Trials